DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China · Delayed Price · Currency is CNY 18.50
-0.35 (-1.86%)
Aug 3, 2026, 3:00 PM CST
SHA:603233 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 27,519 | 27,502 | 26,497 | 24,531 | 21,248 | 16,759 |
Revenue Growth | 3.07% | 3.79% | 8.01% | 15.45% | 26.78% | 14.92% |
Gross Profit Gross Profit Growth | 9,491 | 9,410 | 9,074 | 8,736 | 8,022 | 6,374 |
Operating Income Operating Income Growth | 2,076 | 2,036 | 1,547 | 1,796 | 1,590 | 1,101 |
Net Income Net Income Growth | 1,286 | 1,235 | 914.75 | 1,166 | 1,036 | 791.23 |
Earnings Per Share EPS Growth | 1.13 | 1.08 | 0.81 | 1.03 | 0.91 | 0.70 |
EPS Growth | 30.84% | 33.33% | -21.36% | 13.19% | 30.00% | -25.33% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Retail Retail Growth | 22,349 | 21,906 | 20,493 | 19,242 | 15,285 |
Franchise and Distribution Franchise and Distribution Growth | 4,475 | 3,940 | 3,423 | 1,539 | 1,007 |
Other Operations Other Operations Growth | 635.01 | 616.51 | 589.44 | 444.11 | 446.56 |
Total Total Growth | 27,459 | 26,463 | 24,506 | 21,225 | 16,738 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,111 | 6,948 | 6,238 | 4,458 | 4,585 | 2,902 |
Total Debt Total Debt Growth | 5,167 | 5,775 | 7,744 | 6,508 | 5,931 | 5,275 |
Net Cash (Debt) Net Cash Growth | 1,944 | 1,173 | -1,506 | -2,050 | -1,346 | -2,373 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.70 | 1.03 | -1.33 | -1.81 | -1.18 | -2.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,550 | 5,350 | 3,106 | 3,174 | 3,757 | 1,555 |
Capital Expenditures CapEx Growth | -513.64 | -485.64 | -1,480 | -1,797 | -1,035 | -1,295 |
Free Cash Flow Free Cash Flow Growth | 4,037 | 4,865 | 1,626 | 1,377 | 2,722 | 260.05 |
Free Cash Flow Growth | 69.28% | 199.18% | 18.06% | -49.40% | 946.64% | -77.61% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.49% | 34.22% | 34.25% | 35.61% | 37.76% | 38.03% |
Operating Margin | 7.54% | 7.40% | 5.84% | 7.32% | 7.48% | 6.57% |
Pretax Margin | 6.93% | 6.72% | 5.06% | 6.64% | 6.66% | 6.23% |
Profit Margin | 4.67% | 4.49% | 3.45% | 4.75% | 4.87% | 4.72% |
FCF Margin | 14.67% | 17.69% | 6.14% | 5.61% | 12.81% | 1.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.980 | 0.830 | 0.620 | 0.310 | 0.500 | 0.347 |
Dividend Per Share Growth | 33.87% | 33.87% | 100.00% | -38.00% | 43.97% | -24.99% |
Dividend Yield | 5.20% | 4.86% | 4.41% | 1.39% | 1.72% | 1.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.71 | 16.25 | 18.75 | 24.31 | 36.29 | 42.10 |
Forward PE | 15.57 | 16.97 | 16.44 | 23.76 | 31.37 | 28.06 |
P/FCF Ratio | 5.32 | 4.13 | 10.55 | 20.59 | 13.81 | 128.08 |
PS Ratio | 0.78 | 0.73 | 0.65 | 1.16 | 1.77 | 1.99 |